SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
32 hedge funds and large institutions have $6.36M invested in SQZ Biotechnologies Company in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 8 closing their positions.
11% less funds holding
Funds holding: 36 → 32 (-4)
32% less capital invested
Capital invested by funds: $9.35M → $6.36M (-$2.99M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$218K |
| 2 |
Millennium Management
New York
|
+$77.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$26.6K |
| 4 |
SG Americas Securities
New York
|
+$20.2K |
| 5 |
VF
Virtu Financial
New York
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$985K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$119K |
| 3 |
E
Ergoteles
New York
|
-$47.5K |
| 4 |
RC
RBF Capital
San Francisco,
California
|
-$39.2K |
| 5 |
Jane Street
New York
|
-$31.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BTI
26
Blue Trust Inc
Alpharetta,
Georgia
| $3K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $2.39K | -$7.37K | -10,006 | -70% |
|
28
UBS Group
Zurich,
Switzerland
| $1.47K | +$1.93K | +2,624 | New |
|
29
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
30
National Bank of Canada
Montreal,
Quebec, Canada
| $558 | – | – | – |
|
31
Wells Fargo
San Francisco,
California
| $75 | +$1 | +2 | +2% |
|
|
FDCDDQ
32
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $59 | – | – | – |
|
|
6CM
33
683 Capital Management
New York
| – | -$985K | -1,330,889 | Closed |
|
|
E
34
Ergoteles
New York
| – | -$47.5K | -64,215 | Closed |
|
|
35
Jane Street
New York
| – | -$31.8K | -42,919 | Closed |
|
36
Dimensional Fund Advisors
Austin,
Texas
| – | -$15 | -19,402 | Closed |
|
|
AMG
37
Advisors Management Group
La Crosse,
Wisconsin
| – | -$10K | -14,000 | Closed |
|
|
HF
38
HRT Financial
New York
| – | -$9K | -12,987 | Closed |
|
39
Prudential Financial
Newark,
New Jersey
| – | -$8.47K | -11,450 | Closed |
|
40
Citigroup
New York
| – | -$12 | -16 | Closed |
|
SQZ Hedge Fund Activity: Q1 2023 in Review
32 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q1 2023, worth a combined $6.36M — down 32% from $9.35M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SQZ and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Morgan Stanley, adding an estimated $218K. The largest seller was 683 Capital Management, exiting entirely with an estimated $985K sold.
- 32 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q1 2023, down from 36 in Q4 2022.
- Funds reported $6.36M of SQZ Biotechnologies Company stock for Q1 2023, down 32% quarter-over-quarter.
- 4 funds opened new SQZ Biotechnologies Company positions in Q1 2023 and 8 closed out, a net change of -4 holders.
- The largest SQZ Biotechnologies Company buyer in Q1 2023 was Morgan Stanley, an estimated $218K added.
- The largest SQZ Biotechnologies Company seller in Q1 2023 was 683 Capital Management, an estimated $985K sold.
Based on aggregated 13F filings for Q1 2023.